20 The Role of Optical Coherence Tomography in the Management of Age-Related Macular Degeneration and Macular Edema

Oct 8, 2016 by in OPHTHALMOLOGY Comments Off on 20 The Role of Optical Coherence Tomography in the Management of Age-Related Macular Degeneration and Macular Edema

in the Management of Age-Related MacularDegeneration and Macular Edema Pearse A. Keane • Srinivas R. Sadda INTRODUCTION TO OPTICAL COHERENCE TOMOGRAPHY Optical coherence tomography (OCT), first described by Huang et…

read more

25 Neovascular Glaucoma

Oct 8, 2016 by in OPHTHALMOLOGY Comments Off on 25 Neovascular Glaucoma

FIGURE 25.1. Algorithm regarding the management of neovascular glaucoma. CAUSES OF ANTERIOR CHAMBER NEOVASCULARIZATION While many pathologic ocular processes can initiate fibrovascular proliferation, ischemic retinal disease is the most common…

read more

28 Drug Delivery to the Posterior Segment: Challenges

Oct 8, 2016 by in OPHTHALMOLOGY Comments Off on 28 Drug Delivery to the Posterior Segment: Challenges

Segment: Challenges Prithvi Mruthyunjaya In proangiogenic diseases such as neovascular age-related macular degeneration (ARMD) and diabetic retinopathy (DR), there is growing interest in delivery of targeted therapeutic agents to the…

read more

10 Anti-VEGF Therapies in ARMD in Practice

Oct 8, 2016 by in OPHTHALMOLOGY Comments Off on 10 Anti-VEGF Therapies in ARMD in Practice

Anti-Vegf Therapy The FDA approval of anti-VEGF therapy for the treatment of exudative ARMD has heralded a new era for the management of this devastating disease, offering patients and their…

read more

2 Pathophysiology of Retinal Neovascularization

Oct 8, 2016 by in OPHTHALMOLOGY Comments Off on 2 Pathophysiology of Retinal Neovascularization

Neovascularization Robert N. Frank INTRODUCTION The human retinal vasculature is essentially complete at birth in the full-term infant. These vessels elongate with growth of the eye through childhood and adolescence,…

read more

22 PDT—Still an Option?

Oct 8, 2016 by in OPHTHALMOLOGY Comments Off on 22 PDT—Still an Option?

Results: At the month 24 examination for the primary outcome, 53% of verteporfin-treated patients compared with 38% placebo-treated patients lost fewer than 15 letters. In subgroup analyses for predominantly classic…

read more

4 VEGF: The Major Player

Oct 8, 2016 by in OPHTHALMOLOGY Comments Off on 4 VEGF: The Major Player

FIGURE 4.1. Summary diagram of VEGF expression in the developing retina. (Reprinted from Stone et al. J Neurosci. 1995;15:4738–4747, with permission.) In addition to the well-studied transcriptional induction of VEGF…

read more
Get Clinical Tree app for offline access